Limited health insurance coverage of injectable neurotoxins and fillers for gender affirmation: a cross-sectional study of Affordable Care Act silver and Medicaid plans
Background:. Injectable neurotoxins and fillers are potential options for facial gender affirmation for transgender/nonbinary patients. However, the largest barrier to access is cost/insurance coverage. Objective:. The purpose of this article is to assess the extent to which Affordable Care Act (ACA...
Main Authors: | Karin Roszell, MD, Daniel Shumer, MD, Jeffrey Orringer, MD, Frank Wang, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2024-03-01
|
Series: | International Journal of Women's Dermatology |
Online Access: | http://journals.lww.com/10.1097/JW9.0000000000000126 |
Similar Items
-
Premium subsidies, the mandate, and Medicaid expansion: Coverage effects of the Affordable Care Act
by: Frean, Molly, et al.
Published: (2021) -
Health Insurance Coverage before and after the Affordable Care Act in the USA
by: Jesse Patrick, et al.
Published: (2021-05-01) -
After Anterior Cruciate Ligament Injury, Patients With Medicaid Insurance Experience Delayed Care and Worse Clinical Outcomes Than Patients With Non-Medicaid Insurance
by: Matthew T. Kingery, M.D., et al.
Published: (2023-10-01) -
Collaboration Between Oregon’s Chronic Disease Programs and Medicaid to Decrease Smoking Among Medicaid-Insured Oregonians With Asthma
by: R. David Rebanal, MPH, et al.
Published: (2005-11-01) -
Nondiscrimination Protections in Gender-affirming Surgery: US Government’s Proposed Update to Section 1557 of the Affordable Care Act
by: Amitai S. Miller, BA, et al.
Published: (2024-01-01)